Physician profile
Eric S Collier
NPI 1689898173
$1,238.77
in general payments reported to CMS, 2019-2025
15 companies · $72.49 in 2025
The $72.49 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $34.97 · 2021: $438 · 2022: $147 · 2023: $215 · 2024: $51.52 · 2025: $72.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $338.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $253.38 | 2021 | |
| Alcon Vision LLC | $188.08 | 2019-2025 | Rocklatan, Tryptyr |
| Allergan, INC. | $160.44 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $126.42 | 2019-2021 | |
| Rxsight INC | $121.02 | 2022-2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Abbvie INC. | $108.32 | 2022-2025 | Alphagan P, Vuity, Lumigan |
| Bausch & Lomb Americas INC. | $93.33 | 2023-2025 | Miebo, Envista Envy Iol |
| Regeneron Healthcare Solutions, INC. | $36.54 | 2023 | Eylea Hd |
| New World Medical,INC. | $35.02 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $34.17 | 2023 | Syfovre |
| Kala Pharmaceuticals, INC. | $23.26 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.41 | 2019 | |
| Carl Zeiss Meditec, INC. | $19.70 | 2020 | |
| Ocular Therapeutix, INC. | $10.80 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $5.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Collier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.